SUMMARY Forty-three patients with cirrhosis and ascites, 21 with normal renal function, 10 with a progressive functional renal failure (FRF), and 12 with a steady FRF, were investigated for the presence of endotoxaemia by the Limulus lysate test. Endotoxaemia was found in nine patients with FRF and in none of the 21 with normal renal function (p < 0-01). A positive Limulus test was almost exclusively associated with a progressive FRF (eight of 10 patients) and all but one of them died. Renal function improved as endotoxaemia disappeared in the survivor. Endotoxaemia was also associated with haemorrhage due to acute erosions of the gastric mucosa, being present in six of the seven patients who had this complication. Intravascular coagulation was not found in any patient. The Limulus test was positive in the ascitic fluid in 18 of 21 patients tested, although only two of them had peritonitis. These results suggest that endotoxaemia may play a critical role in the development of progressive renal failure and haemorrhagic gastritis in cirrhosis, and emphasise the potential risk of procedures involving reinfusion of ascitic fluid.
Endotoxin, a lipopolysaccharide derived from Gramnegative microbes, has been shown to have several systemic effects in experimental models, including fever (Greisman and Hornick, 1969) , hypotension (Nies et al., 1968) , reduction of renal blood flow (Cavanagh et al., 1970) , intravascular coagulation (McKay, 1973) , and acute erosions in the gastrointestinal tract (Tamakuma et al., 1971) .
In the normal man, endotoxin absorbed from the gut into the portal venous blood is rapidly phagocyted by the Kupffer cells (Ravin et al., 1960) . This mechanism may be impaired, however, in liver disease, and endotoxin may reach the general circulation and produce several systemic effects. This could be important in some manifestations of Reye's syndrome (Cooperstock et al., 1975) and has been shown to be related to both renal failure and haemorrhagic diathesis in fulminant hepatitis (Wilkinson et al., 1974) . The clinical significance of endotoxaemia in cirrhosis has not been extensively studied, although there is evidence indicating that it could occur frequently (Liehr et al., 1975) , and its 'Address for reprint requests: C. C., Liver Unit, Hospital Clinico y Provincial, C/Casanova 143, Barcelona, Spain. Received for publication 3 December 1976 presence has been reported in patients with cirrhosis and renal failure (Wilkinson et al., 1975) .
Patients with cirrhosis of the liver are prone to develop severe episodes of gastrointestinal haemorrhage due to acute erosions of the gastric mucosa, and to present a peculiar type of renal failure, characterised by a reduction of the renal plasma flow and the glomerular filtration rate (GFR), a low urinary sodium concentration, a preserved renal concentrating ability, a normal urine sediment, and a poor prognosis (Vesin, 1962; Summerskill, 1966) . The absence of substantial evidence of pathological changes in the kidneys of these patients has led to this complication being called 'functional renal failure' of cirrhosis (Vesin, 1962; Lieberman, 1970) . In the present study, these serious complications of cirrhosis are associated with the presence of endotoxaemia, as detected by the Limulus lysate assay (Levin and Bang, 1968 Reinhold and Fine (1971) . All glassware used was rendered pyrogen-free as described by Yin et al. (1972) . Amebocyte lysate (01 ml) was added to 0 1 ml of each sample and incubated at 37°C for 24 hours. The samples were examined after one, four, and 24 hours of incubation, and the test was considered positive when a definite gelation occurred. The sensitivity of the lysate preparation used allowed endotoxin concentrations above 1 ng/ml to be detected. In all patients cultures of blood, ascites, and urine were obtained on the day of the endotoxin assay.
The coagulation studies performed in 17 patients included platelet count, prothrombin-time, thrombin time, fibrin degradation products by tanned red blood-cell haemagglutination-inhibition technique, factor V and factor VIII antihaemophilic factor (VIIIAHF) by the one-stage method, and factor VIII antigen (VIIIAGN) by electroimmunodiffusion according to the technique of Laurell (1972 relation between endotoxaemia and the appearance of progressive renal failure and gastrointestinal haemorrhage from acute erosions of the gastric mucosa was reported in patients with cirrhosis of the liver. However, the nature of the present investigation did not allow us to draw definite conclusions about whether this was a causal relationship or whether they were parallel manifestations of advanced liver failure. Nevertheless, there was experimental evidence of a cause-and-effect relationship between the presence of circulating endotoxin, impairment of renal function, and the development of gastrointestinal haemorrhage. Cavanagh et al. (1970) showed that the administration of endotoxin to the primate provokes a rise in renal vascular resistance and a reduction of renal blood flow. Tamakuma et al. (1971) presented evidence that endotoxaemia may produce acute erosions in the gastrointestinal tract in rabbits. On the other hand, the incidence of gastrointestinal bleeding in the course of septic shock and in systemic infections due to Gram-negative organisms in man is higher than in infections by Gram-positive organisms (Altemeier et al., 1972) , and this has been considered to be an endotoxin-related effect.
Functional renal failure in cirrhosis has been regarded as a rapidly progressive complication with a fatal outcome (Summerskill, 1966) , and its appearance has been related to other complications of liver disease, such as haemorrhage or infections, even though, in some cases, no precipitant factors could be found (Summerskill, 1966; Conn, 1973) . Recently, Lieberman (1970) , Bosch (1973), and Rodes et al. (1975) have stressed that patients with cirrhosis and ascites frequently exhibit moderate degrees of renal failure for long periods. Survival of patients with this steady type of functional renal failure is significantly higher than in the classical progressive form. In a recent series, a 50% mortality was reached only after 11 months of follow-up (Rodes et al., 1975) .
In this study, endotoxaemia was found in almost all patients with progressive functional renal failure. On the contrary, only one of the 12 patients with steady functional renal failure and none of the 21 patients with normal renal function had detectable levels of circulating endotoxin. These results suggest that endotoxaemia may play an important role in the appearance of progressive renal failure in cirrhosis with ascites. The failure to detect endotoxaemia in the 'steady' group could be due to the Limulus assay not being sensitive enough to detect very small quantities of circulating endotoxin, although it cannot be excluded that in these patients the renal failure is not related to endotoxaemia. The relationship between endotoxaemia and progressive functional renal failure is emphasised by the progress of the only patient in this series with progressive renal failure who survived, in whom renal function improved as endotoxaemia disappeared (Figure) . A spontaneous improvement of functional renal failure in cirrhosis is observed in a few patients (Goldstein and Boyle, 1965; Conn, 1973) , generally with an improvement in the underlying liver disease.
In this study, endotoxaemia was also associated with gastrointestinal bleeding due to haemorrhagic gastritis. Six of the seven patients with this complication had a positive Limulus test. The pathogenesis of haemorrhagic gastritis remains obscure, but it was not apparently related to intravascular coagulation. In fact, the coagulation studies disclosed no signs of overt intravascular coagulation in any patient, whether endotoxaemia was present or not. The only difference between endotoxin-positive and negative patients was a moreprolonged prothrombin time in the former, which in the absence of signs of increased peripheral consumption should be ascribed to a worse liver function. All patients had very high levels of factor VIIIAGN, confirming previous reports in patients with cirrhosis (Green and Ratnoff, 1974 ). This has not been adequately explained, and the results of the present study suggest that this is not related to an incapacity of the liver to clear circulating endotoxins.
In the absence of overt infection, as was the case in two-thirds of our patients with endotoxaemia, the most likely source of endotoxin is absorption of that produced by enteric organisms. In normal conditions (Ravin et al., 1960) endotoxin is absorbed from the gastrointestinal tract via the portal vein and completely cleared from the blood by the reticuloendothelial cells in the liver (Braude et al., 1955) . Portosystemic shunting in cirrhosis may allow endotoxin to reach the general circulation. On the other hand, there is experimental evidence indicating that, when a venous outflow block is produced in an intestinal loop, endotoxin rapidly diffuses through the intestinal wall (Nolan and Ali, 1972) . It is possible that portal hypertension could act in a similar way, favouring the passage of endotoxin either into the portal venous radicles or directly into the peritoneal cavity, thus explaining our finding of endotoxin in ascites in many patients, even in 11 who did not have detectable endotoxaemia. An alternative way by which endotoxin may reach the ascitic fluid could be that some of the endotoxin present in the portal venous blood subsequently overflows into ascites.
The finding of endotoxin in ascites may raise several theoretical objections about the safety of some procedures currently used in clinical practice, involving the infusion of ascitic fluid. In fact, some of the complications observed during ascitic fluid reinfusion, such as pyrexia and gastrointestinal haemorrhage (Parbhoo et al., 1974; Levy et al., 1975) , may be related to endotoxin. 
